IFL regimen: Difference between revisions
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}}IFL-Modified Saltz Regimen; IFL-Saltz Regimen; IFL Regimen; Irinotecan-Fluorouracil-Leucovorin Regimen ==Overview== {{PAGENAME...") |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[irinotecan]], [[fluorouracil]] and [[leucovorin]], all administered as bolus doses, and used for the treatment of advanced stage [[colorectal cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url =http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63594&ns=NCI_Thesaurus }}</ref> | {{PAGENAME}} refers to a regimen consisting of [[irinotecan]], [[fluorouracil]] and [[leucovorin]], all administered as bolus doses, and used for the treatment of advanced stage [[colorectal cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url =http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63594&ns=NCI_Thesaurus }}</ref> | ||
==Regimen== | ==Regimen== | ||
{{chemo|I|Irinotecan}} | {{chemo|I|Irinotecan}} | ||
{{chemo|F|Fluorouracil}} | {{chemo|F|Fluorouracil}} | ||
{{chemo|L|Leucovorin}} | {{chemo|L|Leucovorin}} | ||
==Indications== | ==Indications== | ||
*Advanced stage [[colorectal cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url =http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63594&ns=NCI_Thesaurus }}</ref> | *Advanced stage [[colorectal cancer]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url =http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63594&ns=NCI_Thesaurus }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] |
Latest revision as of 14:40, 27 March 2015
WikiDoc Resources for IFL regimen |
Articles |
---|
Most recent articles on IFL regimen Most cited articles on IFL regimen |
Media |
Powerpoint slides on IFL regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on IFL regimen at Clinical Trials.gov Clinical Trials on IFL regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on IFL regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on IFL regimen Discussion groups on IFL regimen Patient Handouts on IFL regimen Directions to Hospitals Treating IFL regimen Risk calculators and risk factors for IFL regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for IFL regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:IFL-Modified Saltz Regimen; IFL-Saltz Regimen; IFL Regimen; Irinotecan-Fluorouracil-Leucovorin Regimen
Overview
IFL regimen refers to a regimen consisting of irinotecan, fluorouracil and leucovorin, all administered as bolus doses, and used for the treatment of advanced stage colorectal cancer.[1]
Regimen
IIrinotecan
FFluorouracil
LLeucovorin
Indications
- Advanced stage colorectal cancer.[2]